These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 4125163)
1. Effect of cyanate on sickling. May A; Bellingham AJ; Huehns ER; Beaven GH Lancet; 1972 Mar; 1(7752):658-61. PubMed ID: 4125163 [No Abstract] [Full Text] [Related]
2. Enhancement of filterability of sickle cells by cyanate: an effect independent of oxygen saturation. Wagner SM; Bishop J; Flanigan PW; Bromberg PA; Balcerzak SP J Lab Clin Med; 1975 Mar; 85(3):445-50. PubMed ID: 1117207 [TBL] [Abstract][Full Text] [Related]
3. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation. Jensen M; Bunn HF; Halikas G; Kan YW; Nathan DG J Clin Invest; 1973 Oct; 52(10):2542-7. PubMed ID: 4729047 [TBL] [Abstract][Full Text] [Related]
4. Red cell survival of cyanate reacted sickle cells. Bellingham AJ; May A; Huehns ER Clin Sci; 1972 Apr; 42(4):21P. PubMed ID: 5020279 [No Abstract] [Full Text] [Related]
5. The clinical use of cyanate in sickling. Ranney HM N Engl J Med; 1972 Jul; 287(2):98-100. PubMed ID: 4624186 [No Abstract] [Full Text] [Related]
6. Effects of urea and cyanate on sickling in vitro. Segel GB; Feig SA; Mentzer WC; McCaffrey RP; Wells R; Bunn HF; Shohet SB; Nathan DG N Engl J Med; 1972 Jul; 287(2):59-64. PubMed ID: 5031386 [No Abstract] [Full Text] [Related]
7. Increased survival of sickle-cell erythrocytes after treatment in vitro with sodium cyanate. Gillette PN; Manning JM; Cerami A Proc Natl Acad Sci U S A; 1971 Nov; 68(11):2791-3. PubMed ID: 5288258 [TBL] [Abstract][Full Text] [Related]
8. Review of the development of cyanate as a drug in the treatment of sickle cell anemia. Cerami A Ann N Y Acad Sci; 1974 Nov; 241(0):538-44. PubMed ID: 4611307 [No Abstract] [Full Text] [Related]
9. Cyanate as an inhibitor of red-cell sickling. Cerami A N Engl J Med; 1972 Oct; 287(16):807-12. PubMed ID: 4560520 [No Abstract] [Full Text] [Related]
11. The treatment of sickle-cell disease. Lancet; 1972 Mar; 1(7752):671-2. PubMed ID: 4125168 [No Abstract] [Full Text] [Related]
12. The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia. De Furia FG; Miller DR; Cerami A; Manning JM J Clin Invest; 1972 Mar; 51(3):566-74. PubMed ID: 5011101 [TBL] [Abstract][Full Text] [Related]
13. Preliminary clinical trials with cyanate. Gillette PN; Peterson CM; Manning JM; Cerami A Adv Exp Med Biol; 1972; 28():261-78. PubMed ID: 4628562 [No Abstract] [Full Text] [Related]
14. Relationship between the oxygen affinity and in vitro sickling propensity of carbamylated sickle erythrocytes. Diederich D Biochem Biophys Res Commun; 1972 Feb; 46(3):1255-61. PubMed ID: 5012168 [No Abstract] [Full Text] [Related]
15. Mechanism of sickling in deer erythrocytes. Amma EL; Sproul GD; Wong S; Huisman TH Ann N Y Acad Sci; 1974 Nov; 241(0):605-13. PubMed ID: 4530684 [No Abstract] [Full Text] [Related]
16. Effect of cyanate on red blood cell sickling. Cerami A; Manning JM; Gillette PN; De Furia F; Miller D; Graziano JH; Peterson CM Fed Proc; 1973 Jun; 32(6):1668-72. PubMed ID: 4268029 [No Abstract] [Full Text] [Related]
17. Oxygen affinity independent action of cyanate and 2,3 DPG on sickling. Jensen MC; Bunn HF; Halikas GC; Nathan DG Adv Exp Med Biol; 1972; 28():297-302. PubMed ID: 5085173 [No Abstract] [Full Text] [Related]
18. Homoserine inhibition of in vitro sickling of erythrocytes. Kang SS; Benjamin G Exp Mol Pathol; 1975 Apr; 22(2):220-4. PubMed ID: 1116571 [No Abstract] [Full Text] [Related]
19. The effect of cyanate upon 2,3-diphosphoglyceric acid metabolism. Harkness DR; Roth S; Goldman P; Kim CY J Lab Clin Med; 1974 Apr; 83(4):577-83. PubMed ID: 4361746 [No Abstract] [Full Text] [Related]